Online first
Editorial
Published online: 2024-06-04
Oxidative stress and atherosclerosis: Basic and clinical open issues
Pubmed: 38845438
Abstract
Not available
References
- Violi F, Loffredo L, Carnevale R, et al. Atherothrombosis and oxidative stress: Mechanisms and management in elderly. Antioxid Redox Signal. 2017; 27(14): 1083–1124.
- Pignatelli P, Menichelli D, Pastori D, et al. Oxidative stress and cardiovascular disease: new insights. Kardiol Pol. 2018; 76(4): 713–722.
- Gniwotta C, Morrow JD, Roberts LJ, et al. Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 1997; 17(11): 3236–3241.
- Folcik VA, Nivar-Aristy RA, Krajewski LP, et al. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J Clin Invest. 1995; 96(1): 504–510.
- Iuliano L, Mauriello A, Sbarigia E, et al. Radiolabeled native low-density lipoprotein injected into patients with carotid stenosis accumulates in macrophages of atherosclerotic plaque: Effect of vitamin E supplementation. Circulation. 2000; 101(11): 1249–1254.
- Cheng M, Cheng M, Wei Q. Association of myeloperoxidase, homocysteine and high-sensitivity C-reactive protein with the severity of coronary artery disease and their diagnostic and prognostic value. Exp Ther Med. 2020; 20(2): 1532–1540.
- Kimak E, Zięba B, Duma D, et al. Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease. Lipids Health Dis. 2018; 17(1): 71.
- Guzik TJ, Sadowski J, Guzik B, et al. Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol. 2006; 26(2): 333–339.
- Loffredo L, Martino F, Zicari AM, et al. Enhanced NOX-2 derived oxidative stress in offspring of patients with early myocardial infarction. Int J Cardiol. 2019; 293: 56–59.
- Arca M, Conti B, Montali A, et al. C242T polymorphism of NADPH oxidase p22phox and recurrence of cardiovascular events in coronary artery disease. Arterioscler Thromb Vasc Biol. 2008; 28(4): 752–757.
- Gammelmark A, Nielsen MS, Lundbye-Christensen S, et al. Common polymorphisms in the 5-lipoxygenase pathway and risk of incident myocardial infarction: A Danish case-cohort study. PLoS One. 2016; 11(11): e0167217.
- Dragan PD, Ivan SB, Goran DZ, et al. The role of systemic oxidative status in coronary arterial and peripheral venous blood of patients with unstable angina pectoris. Life (Basel). 2023; 13(7): 1537.
- Rai H, Parveen F, Kumar S, et al. Association of endothelial nitric oxide synthase gene polymorphisms with coronary artery disease: An updated meta-analysis and systematic review. PLoS One. 2014; 9(11): e113363.
- Akagawa M. Protein carbonylation: Molecular mechanisms, biological implications, and analytical approaches. Free Radic Res. 2021; 55(4): 307–320.
- Voziyan PA, Hudson BG. Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage. Cell Mol Life Sci. 2005; 62(15): 1671–1681.
- Mróz K, Paszek E, Baran M, et al. Elevated carbonylated proteins are associated with major cardiovascular events in patients with chronic coronary syndrome: A cohort study. Pol Heart J. 2024 [Epub ahead of print].
- Violi F, Nocella C, Loffredo L, et al. Interventional study with vitamin E in cardiovascular disease and meta-analysis. Free Radic Biol Med. 2022; 178: 26–41.
- Iuliano L, Micheletta F, Maranghi M, et al. Bioavailability of vitamin E as function of food intake in healthy subjects: effects on plasma peroxide-scavenging activity and cholesterol-oxidation products. Arterioscler Thromb Vasc Biol. 2001; 21(10): E34–E37.
